To date, there is a lack of characterization of metabolic markers in migraine studies. Though numerous studies implicate cerebral dysfunction, robust biomarkers are yet to be identified in the migraine brain. It thus follows that identification of specific metabolic changes, potentially influenced by excitatory and inhibitory neurotransmitters, may improve understanding of migraine onset and propagation while opening new avenues for therapy development.
With the goal of evaluating metabolic processes, diffusion-weighed spectroscopy is used to identify longitudinal changes in the in vivo thalamus of an acute rodent of migraine model.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords